U.S. Gas Utilities Stock News

Fresh attention is turning to T. Rowe Price Group (TROW) after 55ip, a J.P. Morgan subsidiary, expanded its collaboration with the asset manager to deliver tax-focused custom model portfolios for financial advisors. See our latest analysis for T. Rowe Price Group. The dual-share class approval and the expanded 55ip partnership come as T. Rowe Price Group’s share price sits at US$99.49, with a 12.04% 1 month share price return but a 5 year total shareholder return of negative 31.28%. This...

Upcoming earnings expectations and why they matter for Universal Health Services Universal Health Services (UHS) is back in focus as analysts expect quarterly earnings of $5.36 per share and revenue of $4.37 billion, with projections pointing to higher net revenues and admissions across both core segments. See our latest analysis for Universal Health Services. The share price has eased in recent months, with a 30 day share price return of a 2.55% decline and a 90 day share price return of an...

Kinder Morgan (KMI) opened 2026 with Q1 results that build on a solid recent run, with Q4 2025 revenue at US$4.5 billion and basic EPS of US$0.45 supported by net income of US$991 million. Over the past few quarters, revenue has moved from US$3.7 billion in Q3 2024 to US$4.0 billion in Q2 2025 and US$4.5 billion in Q4 2025, while basic EPS shifted from US$0.28 to US$0.32 and then to US$0.45. Together, these figures give you a clear sense of the recent earnings trajectory. With a trailing net...

What LyondellBasell Industries (LYB) shareholders are reacting to LyondellBasell Industries (LYB) shares have seen mixed recent performance, with a one-month return of about a 7% decline and a gain of nearly 39% over the past three months, putting the stock on many investors’ radar. See our latest analysis for LyondellBasell Industries. The recent 6.9% 30 day share price decline contrasts with a 38.7% 90 day share price return and a 59.3% year to date share price return, while the 1 year...

If you are wondering whether Annaly Capital Management's share price still reflects fair value after a strong run, this article walks through what the current numbers may be saying about the stock. The stock last closed at US$22.43, with returns of 1.3% over 7 days, 6.4% over 30 days, a 2.1% decline year to date, 35.7% over 1 year, 70.0% over 3 years and 21.4% over 5 years. Recent coverage has focused on Annaly Capital Management's position within the mortgage REIT space and how interest...

Wondering if WEC Energy Group at around US$115.57 is offering fair value or if you are paying up for a premium utility stock? This article unpacks the numbers so you can judge how its current price compares across several valuation lenses. The stock has returned 2.2% over the last 30 days and 8.5% year to date, with a 9.7% return over the past year and longer-term gains of 33.3% over 3 years and 42.7% over 5 years. Recent attention on utilities and power infrastructure has kept investor...

Why an Investor Letter Put Plexus (PLXS) Back on Investors’ Radar Recent commentary in Riverwater Partners’ Q1 2026 investor letter has put Plexus (PLXS) in focus, highlighting activity related to semiconductor equipment demand, new robotics wins, and fresh healthcare orders. See our latest analysis for Plexus. Plexus shares have moved sharply higher in recent months, with a 43.6% 90 day share price return and 99.3% 1 year total shareholder return. This suggests momentum has been building as...

Western Alliance Bancorporation (NYSE:WAL) addressed two significant fraud-related loan charge-offs in Q1 2026, which management believes helps clear legacy credit risk. The bank reported $5.6b in Q1 deposit growth and plans to shift from aggressive deposit gathering to a more balanced growth approach. These moves are intended to refine Western Alliance's risk management and funding profile following a period of strong deposit inflows. Western Alliance Bancorporation enters this shift with...

Clearway Energy recently expanded its clean energy portfolio through new solar and battery acquisitions and secured around 2 GW of long-term power purchase agreements with hyperscalers and utilities, reinforcing its contracted revenue base. This combination of growth projects and data center-linked contracts strengthens the company’s position as a cash-flow-focused clean energy yield vehicle with an emphasis on predictable distributions. Next, we’ll examine how these new hyperscaler power...

Concerns around ServiceNow and IBM earnings have pulled down enterprise software stocks, and Intuit (INTU) has been caught in that sector slump, even though its recent business commentary points to resilient fundamentals and ongoing AI integration. See our latest analysis for Intuit. Intuit’s share price has retreated sharply in 2026, with a 30-day share price return of 11.37% and a 90-day share price return of 32.03%. In contrast, the 1-year total shareholder return of 37.15% and 5-year...

In its recently reported fiscal Q4 and full-year 2024 results, EZCORP announced record revenue and EBITDA margins, 11% year-over-year Q4 revenue growth, a 14% increase in pawn loans outstanding, and the addition of 21 stores across five countries. Management also highlighted rapid uptake of EZ+ Rewards and online payment options alongside a strong mergers-and-acquisitions pipeline, signaling an intensified push to scale both its physical footprint and digital customer channels. We’ll now...

Arm Holdings (NasdaqGS:ARM) is drawing fresh attention after introducing its first in-house Arm AGI CPU for AI data centers, paired with new alliances spanning Meta Platforms, SK Telecom and Rebellions. See our latest analysis for Arm Holdings. Arm’s latest alliances and AGI CPU launch arrive after a strong run in the stock, with a 30 day share price return of 51.61% and a 1 year total shareholder return of 82.67%. This suggests momentum has recently accelerated as investors reassess its AI...

Linde recently announced it will report fiscal Q1 2026 results on May 1, 2026, alongside a 7% quarterly dividend increase that extends its 33-year history of raising payouts, underscoring sustained commitment to shareholder returns. Investors may also weigh Linde’s sixth consecutive inclusion in the World’s Most Ethical Companies list, highlighting governance and compliance as key elements of its industrial gases profile. Next, we’ll examine how Linde’s upcoming earnings release and dividend...

MINISO Group Holding (MNSO) has drawn fresh attention after Chairman and CEO Guofu Ye announced plans to buy at least HK$50.0 million of shares with personal funds over the next year. See our latest analysis for MINISO Group Holding. Despite the chairman’s planned HK$50.0 million share purchase, recent momentum has been weak. The latest 30 day share price return of 11.26% and a 1 year total shareholder return of 12.34% point to fading gains. If this insider move has you rethinking where...

If you are wondering whether Marten Transport's current share price reflects its true worth, starting with a clear look at valuation can help you put recent moves into perspective. The stock last closed at US$14.83, with returns of 3.7% over 7 days, 15.3% over 30 days, 29.5% year to date, 13.6% over 1 year, negative 22.0% over 3 years and negative 2.9% over 5 years. This gives a mixed picture of shorter term momentum and longer term performance. Recent coverage of Marten Transport has...

Fluor Corporation recently advanced its transformation from a fixed-price engineering and construction contractor to a more predictable reimbursable-services platform, rebuilding its backlog with higher-quality, lower-volatility contracts. An interesting development is that Fluor is funding a large share repurchase program partly by monetizing its NuScale stake, aiming to make earnings more capital-efficient and shareholder-focused. We’ll now examine how Fluor’s pivot toward reimbursable,...

Spyre Therapeutics (SYRE) is back on investors' radar after reporting positive 12-week induction data from Part A of its Phase 2 SKYLINE trial for SPY001 in moderate to severely active ulcerative colitis. See our latest analysis for Spyre Therapeutics. The positive SKYLINE data landed alongside a $403 million follow on equity offering. Despite a 5.15% 1 day share price decline to $69.24, Spyre still shows a 64.0% 30 day share price return and a very large 3 year total shareholder return. This...

TTM Technologies recently reported strong Q3 2024 operating margins, underpinned by higher revenues, a record approximately US$1.49 billion aerospace and defense backlog, and rising demand from data center computing tied to generative AI. The company is also ramping an automated PCB plant in Penang and building an Ultra HDI facility in Syracuse to support secure, high-end manufacturing needs, moves that could reshape its business mix and cost structure. With these capacity expansions and...

If you are wondering whether JD.com's current share price still offers value or if most of the opportunity is already priced in, this article breaks down what the market is paying for and what that might mean for you. The stock closed at US$29.98, with a 9.1% gain over 30 days, a 4.3% decline over 7 days, a 1.5% return year to date, and longer term returns of a 4.4% decline over 1 year, a 5.6% decline over 3 years, and a 56.2% decline over 5 years. Recent coverage around JD.com has focused...

Why ITT (ITT) Is On Investors’ Radar Today ITT (ITT) has drawn attention after recent share price strength, with the stock closing at $219.10 and showing positive returns over the past week, month and past 3 months. With a market value of about $19.4b and a footprint across transportation, industrial and energy markets, the company’s recent performance is prompting investors to reassess how current pricing lines up with its fundamentals. See our latest analysis for ITT. ITT’s recent share...

SkyWest, Inc. reported past first-quarter 2026 results with revenue of US$1,013.18 million and net income of US$101.69 million, slightly higher than a year earlier, alongside modestly higher earnings per share. The company paired this earnings growth with continued debt reduction, strong free cash flow use, and fleet upgrades including new E175 deliveries and upcoming CRJ450 conversions for United. Now we’ll examine how this combination of solid earnings and fleet expansion may influence...

Investors may be wondering whether Cytokinetics at around US$65.48 is still offering value, or if most of the upside is already reflected in the price. The stock has returned 0.1% over the last week, 9.1% over the past 30 days, 6.1% year to date and 62.4% over the last year, with longer term returns of 73.0% over 3 years and 148.1% over 5 years. Recent coverage has focused on Cytokinetics as a biotech name that investors are watching closely, with attention on how its pipeline and...

Chevron has resumed full production at its Wheatstone LNG facility in Australia after repairs related to cyclone damage. The company has completed an asset swap in Venezuela that increases its stake in heavy oil operations. Both moves come as global energy trade is being reshaped by geopolitical tension and shifting supply routes. For investors tracking NYSE:CVX, these operational updates arrive with the stock trading at $187.6 and showing a 20.3% return year to date and 41.0% over the past...

Investors may be asking whether Centene's current share price reflects its true worth, or if the recent weakness could be setting up a more interesting entry point. Centene's stock closed at US$41.09, with a 5.4% gain over the last 7 days and a 24.6% gain over the last 30 days, while returns sit at a 1.7% decline year to date and a 33.3% decline over the past year. Recent news around Centene has focused on its position in managed care and healthcare services, as investors weigh how policy,...